Literature DB >> 668843

Leishmania tropica and Leishmania mexicana: cross-immunity in mice.

J Alexander, R S Phillips.   

Abstract

Entities:  

Mesh:

Year:  1978        PMID: 668843     DOI: 10.1016/0014-4894(78)90049-8

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  6 in total

1.  Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.

Authors:  Ingrid Aguilar-Be; Renata da Silva Zardo; Edilma Paraguai de Souza; Gulnara Patrícia Borja-Cabrera; Miguel Rosado-Vallado; Mirza Mut-Martin; Maria del Rosario García-Miss; Clarisa Beatriz Palatnik de Sousa; Eric Dumonteil
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum.

Authors:  Audrey Romano; Nicole A Doria; Jonatan Mendez; David L Sacks; Nathan C Peters
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

3.  Sex-determined susceptibility and differential IFN-gamma and TNF-alpha mRNA expression in DBA/2 mice infected with Leishmania mexicana.

Authors:  A Satoskar; J Alexander
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

4.  Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.

Authors:  J Alexander; P M Kaye
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

5.  Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.

Authors:  G F Grimaldi; P L Moriearty; R Hoff
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

6.  A common major surface antigen on amastigotes and promastigotes of Leishmania species.

Authors:  V Colomer-Gould; L Glvao Quintao; J Keithly; N Nogueira
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.